Rolziracetam
From Wikipedia, the free encyclopedia
![]() |
|
![]() |
|
Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
|
|
Synonyms | 2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione |
CAS Number | 18356-28-0 ![]() |
PubChem (CID) | 71893 |
ChemSpider | 64906 ![]() |
UNII | RES9I0LGG5 ![]() |
ChEMBL | CHEMBL51396 ![]() |
Chemical and physical data | |
Formula | C7H9N2O2 |
Molar mass | 139.152 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Rolziracetam is a nootropic drug of the racetam family.
Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects. [1]
See also[edit]
References[edit]
- ^ Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 1987 Mar;30(3):498-503.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |